177 related articles for article (PubMed ID: 14629744)
1. Phenylephrine induces endogenous noradrenaline release in the rat vas deferens through nitric oxide synthase pathway.
Pinto R; Barrento C; Mota-Filipe H; Lima BS
Pharmacol Toxicol; 2003 Oct; 93(4):191-6. PubMed ID: 14629744
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase/guanylate cyclase pathway modulates the rat vas deferens contractility induced by phenylephrine.
Pinto R; Mota-Filipe H; Lima BS
Pharmacol Toxicol; 2002 Oct; 91(4):179-84. PubMed ID: 12530468
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
Burt RP; Chapple CR; Marshall I
Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
Aboud R; Shafii M; Docherty JR
Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
[TBL] [Abstract][Full Text] [Related]
5. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
Adeagbo AS; Triggle CR
Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
7. Influence of castration on the response of the rat vas deferens to fluoxetine.
Busch L; Wald M; Borda E
Pharmacol Res; 2000 Oct; 42(4):305-11. PubMed ID: 10987988
[TBL] [Abstract][Full Text] [Related]
8. Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat.
Priest RM; Hucks D; Ward JP
Br J Pharmacol; 1997 Dec; 122(7):1375-84. PubMed ID: 9421285
[TBL] [Abstract][Full Text] [Related]
9. Effects of desipramine on prazosin potency at α1A- and α1D-adrenoceptors in rat vas deferens: implications for the α1L-adrenoceptor subclassification.
Docherty JR
Eur J Pharmacol; 2014 Dec; 744():183-9. PubMed ID: 25446564
[TBL] [Abstract][Full Text] [Related]
10. Two new nitric oxide synthase inhibitors: pyridoxal aminoguanidine and 8-quinolinecarboxylic hydrazide selectively inhibit basal but not agonist-stimulated release of nitric oxide in rat aorta.
Pekiner C; Kelicen P; Uma S; Miwa I
Pharmacol Res; 2002 Oct; 46(4):317-20. PubMed ID: 12361692
[TBL] [Abstract][Full Text] [Related]
11. Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.
Sallés J; Badia A
Br J Pharmacol; 1993 Mar; 108(3):678-83. PubMed ID: 8096783
[TBL] [Abstract][Full Text] [Related]
12. Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen.
Teng CM; Guh JH; Ko FN
Eur J Pharmacol; 1994 Nov; 265(1-2):61-6. PubMed ID: 7883030
[TBL] [Abstract][Full Text] [Related]
13. Effect of 7-nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase.
Allawi HS; Wallace P; Pitcher A; Gaffen Z; Bland-Ward PA; Moore PK
Br J Pharmacol; 1994 Sep; 113(1):282-8. PubMed ID: 7529112
[TBL] [Abstract][Full Text] [Related]
14. Effect of the vascular endothelium on contractions induced by noradrenaline and phenylephrine in perforating branch of the human internal mammary artery.
Pesić S; Grbović L; Jovanović A; Radenković M; Stojić D
Pol J Pharmacol; 2003; 55(4):581-93. PubMed ID: 14581717
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness to noradrenaline in aorta from wild-type, nitric oxide synthase-2, nitric oxide synthase-3 and alpha2A/D-adrenoceptor knockout mice.
Vandeputte C; Aiden McCormick P; Docherty JR
Eur J Pharmacol; 2003 Apr; 466(1-2):129-36. PubMed ID: 12679149
[TBL] [Abstract][Full Text] [Related]
16. The nitric oxide synthase inhibitor L-NMMA potentiates noradrenaline-induced vasoconstriction: effects of the alpha2-receptor antagonist yohimbine.
Bruck H; Gössl M; Spitthöver R; Schäfers RF; Kohnle M; Philipp T; Wenzel RR
J Hypertens; 2001 May; 19(5):907-11. PubMed ID: 11393674
[TBL] [Abstract][Full Text] [Related]
17. Involvement of alpha-adrenoceptors in the endothelium-dependent depression of noradrenaline-induced contraction in rat aorta.
Kaneko K; Sunano S
Eur J Pharmacol; 1993 Aug; 240(2-3):195-200. PubMed ID: 8243538
[TBL] [Abstract][Full Text] [Related]
18. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C
Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
Frew JD; Paisley K; Martin W
Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
[TBL] [Abstract][Full Text] [Related]
20. The influence of chronic inhibition of nitric oxide synthesis on contractile and relaxant properties of rat carotid and mesenteric arteries.
Heijenbrok FJ; Mathy MJ; Pfaffendorf M; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):504-11. PubMed ID: 11138842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
